Ccn2 deficiency causes smooth muscle cell de-differentiation and severe atherosclerosis in hyperlipidemic mice
J. H. Larsen, J. Stubbe, H. C. Beck, M. Overgaard, C. A. Lindegaard, D. R. Hansen, R. Goldschmeding, R. R. Rodriguez-Diez, M. Ruiz-Ortega, C. Pyke, R. Wirka, J. S. Lindholt, L. M. Rasmussen, L. B. Steffensen
Abstract
Cellular communication network factor 2 (CCN2/CTGF) is a matricellular protein with an established role in fibrotic diseases and cancers, and therapies targeting CCN2 is currently in Phase II and III clinical trials for idiopathic pulmonary fibrosis, pancreatic cancer and Duchenne Muscular Dystrophy. Recent studies have highlighed a protective role of CCN2 in aortic aneurysm disease, but its role in atherosclerosis remains to be investigated. We identified arteries as having the highest relative expression of CCN2 across 54 human tissues. In aortas, CCN2 was among the highest expressed genes, and in situ hybridization of human internal thoracic arteries revealed vascular smooth muscle cells (SMCs) as its principal source. Hypothesizing a role for CCN2 in SMC phenotype maintenance and athero-protection, we investigated inducible Ccn2 knockout (Ccn2{Delta}/{Delta}) mice in normo- and hyper-lipidemic settings. Induction of hyperlipidemia by single intravenous injection of 1{middle dot}1011 viral genomes of rAAV8-D377Y-mPcsk9 combined with 24 weeks of western type diet resulted in severe enlargement (3-5-fold increase of relative aorta mass compared to wildtype littermates, p < 0.0001) and whitening of Ccn2{Delta}/{Delta} aortas. Oil Red O-staining of en face prepared thoracic aortas showed a marked increase in atherosclerosis in Ccn2{Delta}/{Delta} mice as compared to wildtype littermates (75% vs. 10% Oil Red O-positive aortic area, p < 0.0001). Transcriptomic profiling of cultivated SMCs derived from aortas of normolipidemic mice showed signatures of dedifferentiation (reduced expression of e.g. Myocd, Acta2 and Myh11) and modulation toward a synthetic, pro-inflammatory phenotype of Ccn2{Delta}/{Delta} SMCs. These effects were verified in vivo and in CCN2-silenced human aortic SMCs. Taken together, we find that CCN2 plays a critical athero-protective role in artery tissues, likely through maintaining SMCs in a differentiated, contractile phenotype.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Conditional deletion of Ccl2 in smooth muscle cells does not reduce early atherosclerosis in mice
S. Gunnersen, J. T. Shim, … J. F. Bentzon·bioRxiv·Aug 6, 2023
- MyD88-dependent signaling promotes smooth muscle cell phenotypic modulation and fibrous cap formation in murine atherosclerosis
Stine Gunnersen, Julián Albarrán-Juárez, … Jacob Fog Bentzon·bioRxiv·Jul 1, 2025
- Endothelial NCK2 Promotes Atherosclerosis Progression in Male but not Female Nck1-null Atheroprone Mice
B. C. Bywaters, G. Pedraza, … G. Rivera·bioRxiv·Jun 30, 2022
- The environment-sensing aryl-hydrocarbon receptor inhibits the chondrogenic fate of modulated smooth muscle cells in atherosclerotic lesions
Juyong Brian Kim, Quanyi Zhao, … Thomas Quertermous·CirculationPeer-reviewed·May 22, 2020
- CCL2/CCR2 inhibition in atherosclerosis: a meta-analysis of preclinical studies
L. Zivkovic, Y. Asare, … M. K. Georgakis·bioRxiv·Apr 16, 2021
- ARF6 controls VSMC cell phenotypic switching upon lipid stimulation to promote inflammatory signaling contributing to the progression of atherosclerosis
Emilie Fiola-Masson, Shirley L. Campbell, … Audrey Claing·bioRxiv·Sep 16, 2025